Menu
Sign In Search Podcasts Charts People & Topics Add Podcast API Blog Pricing

Sydney Lepkin

๐Ÿ‘ค Speaker
241 total appearances

Appearances Over Time

Podcast Appearances

NPR News Now
NPR News: 11-18-2025 8PM EST

The Sackler family will pay up to $7 billion to produce creditors as part of the plan.

NPR News Now
NPR News: 11-18-2025 8PM EST

The arrangement will also provide a pool of up to $865 million to compensate individual victims.

NPR News Now
NPR News: 11-18-2025 8PM EST

The plan was approved by Judge Sean Lane.

NPR News Now
NPR News: 11-18-2025 8PM EST

of the United States Bankruptcy Court for the Southern District of New York.

NPR News Now
NPR News: 11-18-2025 8PM EST

Purdue will dissolve and emerge as a new company, Noah Pharma.

NPR News Now
NPR News: 11-18-2025 8PM EST

Its focus will include overdose reversal medicines, and it will not involve the Sacklers.

NPR News Now
NPR News: 11-18-2025 8PM EST

Sydney Lepkin, NPR News.

NPR News Now
NPR News: 11-17-2025 3PM EST

People buying Wagovi directly from Novo Nordisk will now be able to get it for around $350 a month.

NPR News Now
NPR News: 11-17-2025 3PM EST

Until the end of next March, the company will offer the first two months doses at around $200 a month.

NPR News Now
NPR News: 11-17-2025 3PM EST

That's down from about $500 a month.

NPR News Now
NPR News: 11-17-2025 3PM EST

And patients can get the same discount from Costco, GoodRx, Weight Watchers, and Rho, according to the company.

NPR News Now
NPR News: 11-17-2025 3PM EST

The lower price is only available to patients not using their health insurance.

NPR News Now
NPR News: 11-17-2025 3PM EST

Novo Nordisk's announcement follows the Trump administration's deals with Novo Nordisk and Eli Lilly earlier this month.

NPR News Now
NPR News: 11-17-2025 3PM EST

The deals included lower direct-to-consumer costs of the company's blockbuster obesity drugs.

NPR News Now
NPR News: 11-17-2025 3PM EST

But even the discounted prices will still be too high for many patients.

NPR News Now
NPR News: 11-17-2025 3PM EST

Sydney Lepkin, NPR News.

NPR News Now
NPR News: 11-14-2025 2PM EST

The number of adults taking GLP-1 drugs, which include Ozempic, Wegovy, Zephound, and Manjaro, is going up.

NPR News Now
NPR News: 11-14-2025 2PM EST

It went from 6% a year and a half ago to 12% now.

NPR News Now
NPR News: 11-14-2025 2PM EST

People are taking the drugs for chronic conditions like type 2 diabetes and heart disease, as well as for weight loss.

NPR News Now
NPR News: 11-14-2025 2PM EST

Here's Ashley Kurtzinger, a pollster at KFF.